| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/10/1993 | CN1069650A Making method of aerosol membrane for wound |
| 03/10/1993 | CA2077369A1 Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same |
| 03/09/1993 | US5192802 Bioadhesive pharmaceutical carrier |
| 03/09/1993 | US5192752 Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
| 03/09/1993 | US5192744 Thrombospondin |
| 03/09/1993 | US5192743 Topical gel mixture with glycerol, tissue factor, and cellulose ether |
| 03/09/1993 | US5192741 Sustained and controlled release of water insoluble polypeptides |
| 03/09/1993 | US5192552 Process for preparing microcapsules providing the rapid release of a drug as active ingredient |
| 03/09/1993 | US5192550 Dosage form for treating central nervous system disorders |
| 03/09/1993 | US5192549 Ammonium gradient, sustained release, doxorubicin, acridine orange |
| 03/09/1993 | US5192548 Device |
| 03/09/1993 | US5192544 Cosmetic or pharmaceutical composition for topical application containing at least one retinoid derivative and at least one pyrimidine derivative, its use as a medicinal product and corresponding treatment process |
| 03/09/1993 | US5192535 Ophthalmic suspensions |
| 03/09/1993 | US5192528 Corticosteroid inhalation treatment method |
| 03/09/1993 | US5192527 Method of reversing local anesthesia and reagent system therefor |
| 03/09/1993 | CA1314231C Ifosphamide lyophilisate and process for its preparation |
| 03/09/1993 | CA1314227C Pharmaceutical composition containing ketotifen |
| 03/09/1993 | CA1314218C Remote administration of hyaluronic acid to mammals |
| 03/09/1993 | CA1314217C Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 03/09/1993 | CA1314216C Controlled release tablet |
| 03/09/1993 | CA1314215C Liquid suspension for oral administration |
| 03/09/1993 | CA1314214C Antineoplastic agent-entrapping liposomes |
| 03/09/1993 | CA1314213C Phospholipid delivery vehicle for aqueous-insoluble active ingredients |
| 03/09/1993 | CA1314212C Stable parmaceutical w/o emulsion composition |
| 03/09/1993 | CA1314209C Composition and method for use for liposome encapsulated compounds for neutron capture tumor therapy |
| 03/06/1993 | CA2076722A1 Pharmaceutical agents |
| 03/05/1993 | CA2062303A1 Method of preparation of nanocapsules |
| 03/04/1993 | WO1993004195A1 Reagent compositions for analytical testing |
| 03/04/1993 | WO1993003901A1 Implantable immunoisolated therapeutic devices |
| 03/04/1993 | WO1993003772A1 Imaging of infections |
| 03/04/1993 | WO1993003767A1 Improved transdermal formulations |
| 03/04/1993 | WO1993003753A1 Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 03/04/1993 | WO1993003751A1 Compositions and methods for the sublingual or buccal administration of therapeutic agents |
| 03/04/1993 | WO1993003747A1 STABILIZED IL-1α PHARMACEUTICAL PREPARATION |
| 03/04/1993 | WO1993003744A1 Process for producing preserved medicaments containing human proteins for the purposes of infusion or injection |
| 03/04/1993 | WO1993003739A1 Biocompatible and biodegradable poly(phosphoester-urethanes) |
| 03/04/1993 | WO1993003737A1 Hiv-treatment method with low-toxicity amphotericin b |
| 03/04/1993 | WO1993003731A1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| 03/04/1993 | WO1993003718A1 Pharmaceutical composition containing carbachol and other cholinergic substances |
| 03/04/1993 | WO1993003712A1 A device for the administration of homeopathic compositions |
| 03/04/1993 | WO1993003711A1 Dosage form for delivering drug in short-time period |
| 03/04/1993 | WO1993003710A1 A method of making biocompatible capsules containing cells |
| 03/04/1993 | WO1993003709A1 Composition and method for treating cystic fibrosis |
| 03/04/1993 | WO1993003708A1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases |
| 03/04/1993 | WO1993003697A1 Transdermal formulations for administering prazosin |
| 03/04/1993 | WO1993003696A1 Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset |
| 03/04/1993 | WO1993003694A1 Transdermal administration of short or intermediate half-life benzodiazepines |
| 03/04/1993 | WO1993003693A1 Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset |
| 03/04/1993 | WO1993003692A1 Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
| 03/04/1993 | WO1993003649A1 Sustained-release martrices for dental application |
| 03/04/1993 | DE4129309A1 Liq. dosage forms of sparingly soluble drug e.g. ciprofloxacin - contain alkyl lactam as adjuvant, opt. surfactant, pref., e.g. fatty acid and/or miscible diluent |
| 03/04/1993 | DE4128693A1 Oel-in-wasser-emulsionen polarer oelkomponenten Oil-in-water emulsions-polar oelkomponenten |
| 03/04/1993 | DE4128260A1 Verfahren zur herstellung eines phenylalaninfreien diaetetikums in dragee- oder tablettenform Process for the preparation of a phenylalanine-free dietetic or coated tablet in tablet form |
| 03/04/1993 | DE4120760A1 Traegersysteme fuer arzneimittel Carrier systems for drug |
| 03/04/1993 | CA2115841A1 Transdermal administration of short or intermediate half-life benzodiazepines |
| 03/04/1993 | CA2115840A1 Transdermal formulation for administering prazosin |
| 03/04/1993 | CA2115831A1 Improved transdermal formulations |
| 03/04/1993 | CA2115664A1 A method of making biocompatible capsules containing cells |
| 03/04/1993 | CA2115570A1 Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
| 03/04/1993 | CA2115364A1 Composition and method for treating cystic fibrosis |
| 03/04/1993 | CA2113272A1 Hiv-treatment method with low-toxicity amphotericin b |
| 03/03/1993 | EP0529931A2 Water modifier |
| 03/03/1993 | EP0529852A1 Melt crystallized xylitol |
| 03/03/1993 | EP0529711A1 Process of continuous preparation of disperse colloidal systems in the form of nanocapsules or nanoparticles |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529484A1 Antitussive and expectorant composition |
| 03/03/1993 | EP0529396A1 Galenic matrix |
| 03/03/1993 | EP0529123A1 Pharmaceutical preparation for percutaneous absorption |
| 03/03/1993 | EP0528998A1 Periodontal tissue regeneration barrier and method. |
| 03/03/1993 | EP0528978A1 Controlled release dopamine and its use to stimulate nerve fiber growth |
| 03/03/1993 | EP0528971A1 Surgical implant and method incorporating chemotherapeutic agents |
| 03/03/1993 | EP0528862A1 Composition for solid pharmaceutical preparations containing vitamin d 3? derivative and process for preparation thereof |
| 03/03/1993 | EP0528834A1 Enzymatic synthesis of soluble phosphatides from phospholipids. |
| 03/03/1993 | EP0446225B1 Medicament for treatment of pathological vascular permeability and plasma loss to tissue |
| 03/03/1993 | EP0443007A4 An external analgesic lotion and method of making |
| 03/03/1993 | EP0394314B1 Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| 03/03/1993 | EP0390930B1 Stable aqueous preparation of active vitamin d 3 |
| 03/03/1993 | EP0388428B1 $i(IN VIVO) DELIVERY OF NEUROTRANSMITTERS BY IMPLANTED, ENCAPSULATED CELLS |
| 03/03/1993 | EP0233901B1 A method and composition for regulating serum calcium levels of mammals |
| 03/03/1993 | EP0153407B1 Injectable physiologically acceptable polymeric compositions |
| 03/03/1993 | CN1069410A Preparing method for medical oral gum |
| 03/03/1993 | CN1069409A Process technology of medicine containing adhesive component |
| 03/03/1993 | CN1069408A Pharmaceuctical spheroid formulation |
| 03/02/1993 | US5191114 Process for enhancing the flow characteristics of ibuprofen |
| 03/02/1993 | US5190936 Process for improving the therapeutic efficacy of fat-soluble corticosteroids and composition for carrying out this process |
| 03/02/1993 | US5190917 Mast cell and T-cell inhibitor |
| 03/02/1993 | US5190822 Surface-modifiable liposome and process for producing surface-modified liposome |
| 03/02/1993 | US5190775 Encapsulated bioactive substances |
| 03/02/1993 | US5190766 Administering anticancer drugs to specific locations in human bodies |
| 03/02/1993 | US5190765 Latent Drug Delivery |
| 03/02/1993 | US5190763 Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
| 03/02/1993 | US5190762 DNA repair enzymes encapsulated in liposomes |
| 03/02/1993 | US5190761 Electromagnetic field triggered drug and chemical delivery via liposomes |
| 03/02/1993 | US5190760 Solid pharmaceutical composition |
| 03/02/1993 | US5190748 Cephalosporins with ethylene oxide fatty alcohol derivatives and caprylic acid salts |
| 03/02/1993 | US5190029 Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| 03/02/1993 | US5189986 Veterinary transdermal active agent delivery device |
| 03/02/1993 | CA1314045C 6' carbamate esters of zearalanol and its derivatives |
| 03/01/1993 | CA2077186A1 Microemulsions |
| 02/28/1993 | CA2076114A1 Antitussive and expectorant composition |